Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Cate

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Medical Virology|January 1, 1983
Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccineJ M Zahradnik, J A Kasel, R R Martin, et al.
Hospital Formulary|May 1, 1994
Concurrent ceftazidime DUE with clinical pharmacy interventionA U Okpara, O M Van Duyn, T R Cate, et al.
The Journal of Infectious Diseases|February 1, 1993
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adultsW A Keitel, R B Couch, J M Quarles, et al.
The Journal of Infectious Diseases|December 1, 1981
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adultsP Anderson, R A Insel, D H Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomesA C White, R L Atmar, J Wilson, et al.
Archives of Internal Medicine|September 1, 1975
Fungal infection following renal transplantationH A Gallis, R A Berman, T R Cate, et al.
Vaccine|November 1, 1994
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus proteinI N Mbawuike, S B Dillion, S G Demuth, et al.
The Journal of Infectious Diseases|December 9, 2000
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adultsW A Keitel, T R Cate, D Nino, et al.
Developments in Biological Standardization|June 1, 1977
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteersB R Murphy, L J Markoff, R M Chanock, et al.
Journal of Clinical Microbiology|October 1, 1994
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adultsW A Keitel, R B Couch, T R Cate, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Medical Virology|January 1, 1983
Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccineJ M Zahradnik, J A Kasel, R R Martin, et al.
Hospital Formulary|May 1, 1994
Concurrent ceftazidime DUE with clinical pharmacy interventionA U Okpara, O M Van Duyn, T R Cate, et al.
The Journal of Infectious Diseases|February 1, 1993
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adultsW A Keitel, R B Couch, J M Quarles, et al.
The Journal of Infectious Diseases|December 1, 1981
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adultsP Anderson, R A Insel, D H Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomesA C White, R L Atmar, J Wilson, et al.
Archives of Internal Medicine|September 1, 1975
Fungal infection following renal transplantationH A Gallis, R A Berman, T R Cate, et al.
Vaccine|November 1, 1994
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus proteinI N Mbawuike, S B Dillion, S G Demuth, et al.
The Journal of Infectious Diseases|December 9, 2000
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adultsW A Keitel, T R Cate, D Nino, et al.
Developments in Biological Standardization|June 1, 1977
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteersB R Murphy, L J Markoff, R M Chanock, et al.
Journal of Clinical Microbiology|October 1, 1994
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adultsW A Keitel, R B Couch, T R Cate, et al.
Pageof 7